--(BUSINESS WIRE)--Genomind, a leader in medication management and personalized medicine through pharmacogenetics (PGx), is proud to announce the release of its innovative Patient Report. This new ...
Cadrenal Therapeutics, Inc., (Nasdaq: CVKD) (the "Company" or "Cadrenal"), a late-stage biopharmaceutical company developing tecarfarin, a new vitamin K antagonist (VKA) designed to provide safer and ...
If standard therapies don’t give relief to patients with refractory cough associated ... Berman told Medscape Medical News. Su did not report a study funding source. Su, Balasubramanian, and ...
(NASDAQ: PAYS), a leading provider of prepaid card programs, comprehensive patient affordability offerings, digital banking services and integrated payment processing, today announced financial ...
About 80 per cent of New Brunswick hospital patients report having a very good overall experience, according to a survey released Tuesday by the New Brunswick Health Council. But the comments ...